Cytokinetics Inc (CYTK)
Quick ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 94,857 | 113,024 | 65,582 | 112,666 | 82,985 |
| Short-term investments | US$ in thousands | 981,157 | 501,800 | 716,995 | 358,972 | 381,075 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 179,674 | 102,678 | 84,617 | 71,860 | 31,199 |
| Quick ratio | 5.99 | 5.99 | 9.25 | 6.56 | 14.87 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($94,857K
+ $981,157K
+ $—K)
÷ $179,674K
= 5.99
The quick ratio for Cytokinetics Inc has shown fluctuations over the years. As of December 31, 2020, the quick ratio was a significant 14.87, indicating a strong ability to meet its short-term obligations with its most liquid assets. However, by December 31, 2021, the quick ratio had decreased to 6.56, suggesting a potential decrease in liquidity.
Subsequently, the quick ratio improved to 9.25 by December 31, 2022, indicating a better ability to cover short-term liabilities. However, by December 31, 2023, the quick ratio dropped to 5.99, potentially signaling a strain on short-term liquidity.
By December 31, 2024, the quick ratio remained stable at 5.99, indicating that the company may still have some room for improvement in terms of its ability to quickly cover its short-term obligations with its liquid assets. Overall, fluctuations in the quick ratio suggest varying levels of liquidity and the need for careful monitoring and management of short-term financial health.
Peer comparison
Dec 31, 2024